Development and initial testing of the stroke rapid-treatment readiness tool.
J Neurosci Nurs
; 46(5): 267-73, 2014 Oct.
Article
en En
| MEDLINE
| ID: mdl-25099063
No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Terapia Trombolítica
/
Infarto Cerebral
/
Activador de Tejido Plasminógeno
/
Adhesión a Directriz
/
Intervención Médica Temprana
Tipo de estudio:
Prognostic_studies
/
Qualitative_research
Límite:
Humans
Idioma:
En
Revista:
J Neurosci Nurs
Asunto de la revista:
ENFERMAGEM
/
NEUROCIRURGIA
/
NEUROLOGIA
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Estados Unidos